Leukemia Research
Volume 29, Issue 6 , Pages 649-652, June 2005

Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes

The University of Texas, M.D. Anderson Cancer Center, Department of Leukemia, Box 428, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA

Received 25 August 2004; accepted 15 November 2004. published online 07 March 2011.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0145-2126(04)00397-2

doi:10.1016/j.leukres.2004.11.013

Leukemia Research
Volume 29, Issue 6 , Pages 649-652, June 2005

Article Tools

* Image Usage & Resolution